Archer Investment Corp Increases Stock Position in Lam Research Corporation $LRCX

Archer Investment Corp grew its stake in Lam Research Corporation (NASDAQ:LRCX) by 235.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,673 shares of the semiconductor company’s stock after buying an additional 2,579 shares during the period. Archer Investment Corp’s holdings in Lam Research were worth $492,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. IMG Wealth Management Inc. bought a new position in Lam Research in the second quarter valued at $26,000. Howard Hughes Medical Institute purchased a new position in shares of Lam Research in the 2nd quarter worth about $27,000. Strategic Wealth Investment Group LLC bought a new position in shares of Lam Research during the 2nd quarter valued at about $29,000. Delos Wealth Advisors LLC purchased a new position in shares of Lam Research during the 2nd quarter valued at about $30,000. Finally, REAP Financial Group LLC purchased a new position in shares of Lam Research during the 2nd quarter valued at about $31,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Q2 earnings and revenue beat consensus — Lam reported $1.27 EPS vs. $1.17 expected and $5.34B revenue vs. $5.23B expected, with margins and ROE notably strong (y/y revenue +22%). Lam Research (LRCX) Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Raised Q3 guidance: EPS guide $1.25–1.45 (above $1.20 consensus) and revenue guide $5.4–6.0B (above ~$5.3B consensus) — investors view this as confirmation of stronger WFE demand. Lam Research Corporation Reports Financial Results for the Quarter Ended December 28, 2025
• Positive Sentiment: Management and news outlets cite rising enterprise orders and strong chipmaking-tool demand underpinning the upbeat forecast — a demand-driven beat/guide is taken as durable upside for revenue visibility. Lam Research forecasts strong quarterly results on chipmaking tool demand
• Positive Sentiment: Analyst interest and upgrades: coverage notes (including Evercore/other firms) and at least one upgrade have lifted sentiment and trading interest. Lam Research (NASDAQ:LRCX) Stock Price Up 2.3% After Analyst Upgrade
• Positive Sentiment: High-profile bullish commentary — Jim Cramer and others highlight a supply shortage and structural tailwinds from AI and advanced-node spending, supporting a longer-term bullish case. Lam Research (LRCX) Has a Shortage That Can’t Be Met, Says Jim Cramer
• Neutral Sentiment: Positive media and analyst previews (Zacks, 24/7 Wall St.) framed expectations ahead of results — helpful for market context but not new fundamentals. Bull of the Day: Lam Research (LRCX)
• Negative Sentiment: Valuation and volatility concerns — commentary warns that LRCX is at record highs and has a history of sharp corrections; investors should weigh upside vs. PE/volatility risk. Why Record Highs For LRCX Stock May Face A Reality Check In 2026
• Negative Sentiment: Geopolitical/China exposure — coverage notes that China-related demand or regulatory developments could weigh on the outlook despite AI tailwinds. Lam Research leans on AI tailwinds as China weighs on outlook

Analysts Set New Price Targets

A number of research analysts have commented on LRCX shares. The Goldman Sachs Group reiterated a “buy” rating and set a $180.00 price target on shares of Lam Research in a research report on Friday, January 9th. UBS Group reaffirmed a “buy” rating and issued a $255.00 price objective (up previously from $200.00) on shares of Lam Research in a research note on Tuesday, January 20th. TD Cowen reiterated a “buy” rating on shares of Lam Research in a research report on Thursday, October 23rd. Morgan Stanley set a $211.00 price target on shares of Lam Research in a research note on Thursday, January 15th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Lam Research in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus target price of $204.26.

Insider Activity at Lam Research

In other news, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares in the company, valued at $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the sale, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 41,408 shares of company stock worth $6,248,501 over the last ninety days. 0.31% of the stock is currently owned by insiders.

Lam Research Trading Up 0.5%

NASDAQ LRCX opened at $239.58 on Thursday. The firm has a market capitalization of $300.92 billion, a PE ratio of 52.77, a P/E/G ratio of 3.01 and a beta of 1.77. The stock’s 50 day moving average is $183.31 and its 200 day moving average is $144.37. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $243.99. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. During the same period last year, the company posted $0.91 EPS. Lam Research’s revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd were issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Wednesday, December 3rd. Lam Research’s payout ratio is presently 22.91%.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.